Completed NA INTERVENTIONAL 2-arm
NCT06484166
Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .
Sponsor: West China Hospital
Conditions
Radiation Dermatitis
Interventions
Fullerene cream Trolamine (Biafine)
Updated 3 times since 2024 Last updated: May 31, 2025 Started: Aug 1, 2024 Primary completion: Mar 1, 2025 Completion: May 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06484166, this NA trial focuses on Radiation Dermatitis and remains completed. Sponsored by West China Hospital, it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Jul 2025 — Present [monthly]
Completed NA
Status: Not Yet Recruiting → Completed
-
Sep 2024 — Jul 2025 [monthly]
Not Yet Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- West China Hospital
Data source: West China Hospital
For direct contact, visit the study record on ClinicalTrials.gov .